Here are the biggest movers of the day:
Stock gainers:
Coherus BioSciences stock
CHRS,
rose 17% as the Food and Drug Administration approved its treatment for nasopharyngeal cancer when combined with chemotherapy that it makes with Shanghai Junshi Biosciences.
Read the full article here
Leave a Reply